These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10336020)

  • 1. Leptin, polycystic ovaries and polycystic ovary syndrome.
    Jacobs HS; Conway GS
    Hum Reprod Update; 1999; 5(2):166-71. PubMed ID: 10336020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropeptide Y, leptin, galanin and insulin in women with polycystic ovary syndrome.
    Baranowska B; Radzikowska M; Wasilewska-Dziubińska E; Kapliński A; Roguski K; Płonowski A
    Gynecol Endocrinol; 1999 Oct; 13(5):344-51. PubMed ID: 10599552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutrition, insulin and polycystic ovary syndrome.
    Franks S; Robinson S; Willis DS
    Rev Reprod; 1996 Jan; 1(1):47-53. PubMed ID: 9414438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroendocrine Regulation of Food Intake in Polycystic Ovary Syndrome.
    Romualdi D; Immediata V; De Cicco S; Tagliaferri V; Lanzone A
    Reprod Sci; 2018 May; 25(5):644-653. PubMed ID: 28874103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: role of hyperinsulinism.
    Romualdi D; De Marinis L; Campagna G; Proto C; Lanzone A; Guido M
    Clin Endocrinol (Oxf); 2008 Oct; 69(4):562-7. PubMed ID: 18248643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum leptin levels in women with polycystic ovary syndrome: the role of insulin resistance/hyperinsulinemia.
    Laughlin GA; Morales AJ; Yen SS
    J Clin Endocrinol Metab; 1997 Jun; 82(6):1692-6. PubMed ID: 9177365
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.
    Tolino A; Gambardella V; Caccavale C; D'Ettore A; Giannotti F; D'Antò V; De Falco CL
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar; 119(1):87-93. PubMed ID: 15734091
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin resistance and polycystic ovarian syndrome.
    Dewailly D; Cortet-Rudelli C
    Horm Res; 1992; 38(1-2):41-5. PubMed ID: 1306514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular mechanisms of insulin resistance in polycystic ovary syndrome.
    Diamanti-Kandarakis E; Papavassiliou AG
    Trends Mol Med; 2006 Jul; 12(7):324-32. PubMed ID: 16769248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum leptin levels correlate with clinical and biochemical indices of insulin resistance in women with polycystic ovary syndrome.
    Pehlivanov B; Mitkov M
    Eur J Contracept Reprod Health Care; 2009 Apr; 14(2):153-9. PubMed ID: 19340711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polycystic ovary syndrome and insulin: our understanding in the past, present and future.
    Mayer SB; Evans WS; Nestler JE
    Womens Health (Lond); 2015 Mar; 11(2):137-49. PubMed ID: 25776288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Polycystic Ovary Morphology-Polycystic Ovary Syndrome Spectrum.
    Rosenfield RL
    J Pediatr Adolesc Gynecol; 2015 Dec; 28(6):412-9. PubMed ID: 25840648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New markers of insulin resistance in polycystic ovary syndrome.
    Polak K; Czyzyk A; Simoncini T; Meczekalski B
    J Endocrinol Invest; 2017 Jan; 40(1):1-8. PubMed ID: 27473078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum kisspeptin, leptin, neuropeptide Y, and neurokinin B levels in adolescents with polycystic ovary syndrome.
    Guzelkas I; Orbak Z; Doneray H; Ozturk N; Sagsoz N
    J Pediatr Endocrinol Metab; 2022 Apr; 35(4):481-487. PubMed ID: 35170267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin action in the polycystic ovary syndrome.
    Dunaif A
    Endocrinol Metab Clin North Am; 1999 Jun; 28(2):341-59. PubMed ID: 10352922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A study of ghrelin and leptin levels and their relationship to metabolic profiles in obese and lean Saudi women with polycystic ovary syndrome (PCOS).
    Daghestani MH; Daghestani M; Daghistani M; El-Mazny A; Bjørklund G; Chirumbolo S; Al Saggaf SH; Warsy A
    Lipids Health Dis; 2018 Aug; 17(1):195. PubMed ID: 30131073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abdominal adiposity and the polycystic ovary syndrome.
    Escobar-Morreale HF; San Millán JL
    Trends Endocrinol Metab; 2007 Sep; 18(7):266-72. PubMed ID: 17693095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is there a role for leptin in the endocrine and metabolic aberrations of polycystic ovary syndrome?
    Gennarelli G; Holte J; Wide L; Berne C; Lithell H
    Hum Reprod; 1998 Mar; 13(3):535-41. PubMed ID: 9572406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ovarian insulin resistance and insulin sensitizer effect on polycystic ovary syndrome].
    Wu XK; Risto E
    Zhonghua Fu Chan Ke Za Zhi; 2004 Dec; 39(12):804-8. PubMed ID: 15733404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.